References

References

1. Adair CD, Gunter M, Stovall TG, et al: Chlamydia in pregnancy: A randomized trial of azithromycin and erythromycin. Obstet Gynecol 91:165, 1998
   
2. Adimora AA: Treatment of uncomplicated genital Chlamydia trachomatis infections in adults. Clin Infect Dis 35:S183, 2002
   
3. Alexander JM, Sheffield JS, Sanchez PJ, et al: Efficacy of treatment for syphilis in pregnancy. Obstet Gynecol 93:5, 1999
   
4. Alger LS, Lovchik JC, Hebel JR, et al: The association of Chlamydia trachomatis, Neisseria gonorrhoeae, and group B streptococci with preterm rupture of the membranes and pregnancy outcome. Am J Obstet Gynecol 159:397, 1988
   
5. American Academy of Pediatrics and American College of Obstetricians and Gynecologists: Guidelines for Perinatal Care, 5th ed. Washington, DC, AAP and ACOG, 2002
   
6. American College of Obstetricians and Gynecologists: Prenatal and perinatal human immunodeficiency virus testing: expanded recommendations. Committee Opinion No. 304, November 2004
   
7. American College of Obstetricians and Gynecologists: Scheduled cesarean delivery and the prevention of vertical transmission of HIV infection. Committee Opinion No. 234, May 2000
   
8. American College of Obstetricians and Gynecologists: Management of herpes in pregnancy. Practice Bulletin No. 8, October 1999a
   
9. American College of Obstetricians and Gynecologists: Joint Statement on human immunodeficiency virus screening. Policy Statements, Compendium of Selected Publications, May 1999b
   
10. Anderson JE, Ebrahim SH, Sansom S: Women's knowledge about treatment to prevent mother-to-child human immunodeficiency virus transmission. Obstet Gynecol 103:165, 2004
    
11. Andrews WW, Lee H, Roden WJ, et al: Detection of genitourinary tract Chlamydia trachomatis infection in pregnant women by ligase chain reaction assay. Obstet Gynecol 89:556, 1997
    
12. Arena S, Marconi M, Frega A, et al: Pregnancy and condyloma. Evaluation about therapeutic effectiveness of laser CO2 on 115 pregnant women. Minerva Ginecol 53:389, 2001
    
13. Ashley RL: Sorting out the new HSV type specific antibody tests. Sex Trans Infect 77:232, 2001
    
14. Augenbraun MH: Treatment of syphilis 2001: Nonpregnant adults. Clin Infect Dis 35:S187, 2002
    
15. Augenbraun M, Workowski K: Ceftriaxone therapy for syphilis: Report from the Emerging Infections Network. Clin Infect Dis 29:1337, 1999
    
16. Ault K: Human papillomavirus infections: Diagnosis, treatment and hope for a vaccine. Obstet Gynecol Clin North Am 30:809, 2003
    
17. Baker D, Brown Z, Hollier LM, et al: Cost-effectiveness of herpes simplex virus type 2 serologic testing and antiviral therapy in pregnancy. Am J Obstet Gynecol 191:2074, 2004
    
18. Barnabas RV, Carabin H, Garnett GP: The potential role of suppressive therapy for sex partners in the prevention of neonatal herpes: A health economic analysis. Sex Transm Infect 78:425, 2002
    
19. Barton JR, Thorpe EM Jr, Shaver DC, et al: Nonimmune hydrops fetalis associated with maternal infection with syphilis. Am J Obstet Gynecol 167:56, 1992
    
20. Bataskov KL, Hariharan S, Horowitz MD, et al: Gonococcal endocarditis complicating pregnancy: A case report and literature review. Obstet Gynecol 78:494, 1991
    
21. Blair JM, Hanson DL, Jones JL, et al: Trends in pregnancy rates among women with human immunodeficiency virus. Obstet Gynecol 103:663, 2004
    
22. Blanco JD, Diaz KC, Lipscomb KA, et al: Chlamydia trachomatis isolation in patients with endometritis after cesarean section. Am J Obstet Gynecol 152:278, 1985
    
23. Branson BM: Point-of-care rapid tests for HIV antibodies. J Lab Med 27:288, 2003
    
24. Brocklehurst P: Antibiotics for gonorrhoea in pregnancy (Cochrane Review). In The Cochrane Library. Chichester, UK, John Wiley & Sons, Issue 4, 2003
    
25. Brocklehurst P, Kinghorn G, Carney O, et al: A randomized placebo controlled trial of suppressive acyclovir in late pregnancy in women with recurrent genital herpes infection. Br J Obstet Gynaecol 105:275, 1998
    
26. Brown ZA: HSV-2 specific serology should be offered routinely to antenatal patients. Rev Med Virol 10:145, 2000
    
27. Brown ZA, Baker DA: Acyclovir therapy during pregnancy. Obstet Gynecol 73:526, 1989
    
28. Brown ZA, Benedetti J, Ashley R, et al: Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med 324:1247, 1991
    
29. Brown ZA, Vontver LA, Benedetti J, et al: Genital herpes in pregnancy: Risk factors associated with recurrences and asymptomatic shedding. Am J Obstet Gynecol 153:24, 1985
    
30. Brown ZA, Wald A, Morrow A, et al: Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 289:203, 2003
    
31. Bulterys M, Jamieson DJ, O'Sullivan MJ, et al: Rapid HIV-1 testing during labor: A multicenter study. JAMA 292:219, 2004
    
32. Burkman RT, Tonascia JA, Atienza MF, et al: Untreated endocervical gonorrhea and endometritis following elective abortion. Am J Obstet Gynecol 126:648, 1976
    
33. Cejtin HE: Gynecologic issues in the HIV-infected woman. Obstet Gynecol Clin North Am 30:711, 2003
    
34. Centers for Disease Control and Prevention: Azithromycin treatment failures in syphilis infections — San Francisco, California, 2002-2003. MMWR 53:197, 2004a
    
35. Centers for Disease Control and Prevention: Heterosexual transmission of HIV — 29 states. MMWR 53:125, 2004b
    
36. Centers for Disease Control and Prevention: Protocols for confirmation of reactive rapid HIV tests. MMWR 53:221, 2004c
    
37. Centers for Disease Control and Prevention: Rapid HIV antibody testing during labor and delivery for women of unknown HIV status. A practical guide and model protocol. Available at: http://www.cdc.gov/hiv/projects/perinatal. Accessed March 2004d
    
38. Centers for Disease Control and Prevention: Routine prenatal testing — the opt-out approach. Available at: http://www.cdc.gov/hiv/PROJECTS/perinatal/OptOutNews32.pdf. Accessed February 24, 2004e
    
39. Centers for Disease Control and Prevention: Updated guidelines for the use of rifamycins for the treatment of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors. MMWR 53:37, 2004f
    
40. Centers for Disease Control and Prevention: Primary and secondary syphilis — United States, 2002. MMWR 52:1117, 2003a
    
41. Centers for Disease Control and Prevention: Sexually transmitted disease surveillance, 2002. Atlanta, GA: U.S. Department of Health and Human Services, September 2003b
    
42. Centers for Disease Control and Prevention: 2002 IDSA guidelines for preventing opportunistic infections among HIV-infected persons — 2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. MMWR 51:RR-9, 2002a
    
43. Centers for Disease Control and Prevention: Cases of HIV infection and AIDS in the United States, 2002. HIV/AIDS Surveillance Report (Addendum) 14:1, 2002b
    
44. Centers for Disease Control and Prevention: HIV testing among pregnant women — United States and Canada, 1998-2001. MMWR 51:1013, 2002c
    
45. Centers for Disease Control and Prevention: Sexually transmitted diseases treatment guidelines 2002. MMWR 51:RR-6, 2002d
    
46. Centers for Disease Control and Prevention: Revised guidelines for HIV counseling and testing. MMWR 50:1, 2001a
    
47. Centers for Disease Control and Prevention: Revised recommendations for HIV screening of pregnant women. MMWR 50:RR-19, 2001b
    
48. Centers for Disease Control and Prevention: Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR 50:RR-11, 2001c
    
49. Centers for Disease Control and Prevention: Prevention of genital HPV infection and sequelae: Report of an external consultants' meeting. Atlanta, Centers for Disease Control and Prevention, December 1999
    
50. Chisholm CA, Katz VL, McDonald TL, et al: Penicillin desensitization in the treatment of syphilis during pregnancy. Am J Perinatol 14:553, 1997
    
51. Christmas JT, Wendel GD, Bawdon RE, et al: Concomitant infection with Neisseria gonorrhoeae and Chlamydia trachomatis in pregnancy. Obstet Gynecol 74:295, 1989
    
52. Clavel F, Hance AJ: HIV drug resistance. N Engl J Med 350:1023, 2004
    
53. Clinton WJ: Turning the tide on the AIDS pandemic. N Engl J Med 348:1800, 2003
    
54. Cone RW, Hobson AC, Brown Z, et al: Frequent detection of genital herpes simplex virus DNA by polymerase chain reaction among pregnant women. JAMA 272:792, 1994
    
55. Connor N, Roberts J, Nicoll A: Strategic options for antenatal screening for syphilis in the United Kingdom: A cost effectiveness analysis. J Med Screen 7:7, 2000
    
56. Cooper ER, Charurat M, Mofenson L, et al: Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 29:484, 2002a
    
57. Cooper WO, Ray WA, Griffin MR: Prenatal prescription of macrolide antibiotics and infantile hypertrophic pyloric stenosis. Obstet Gynecol 100:101, 2002b
    
58. Corey L, Wald A, Patel R, et al: Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 350:11, 2004
    
59. Cotch MF, Pastorek JG II, Nugent RP, et al: Demographic and behavioral predictors of Trichomonas vaginalis infection among pregnant women. Obstet Gynecol 78:1087, 1991
    
60. Cotch MF, Pastorek JG II, Nugent RP, et al: Trichomonas vaginalis associated with low birth weight and preterm delivery. Sex Transm Dis 24:353, 1997
    
61. Culnane M, Fowler M, Lee SS, et al: Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams. JAMA 13:281, 1999
    
62. De Cock KM, Fowler MG, Mercier E, et al: Prevention of mother-to-child HIV transmission in resource-poor countries. JAMA 283:1175, 2000
    
63. Dorenbaum A, Cunningham CK, Gelber RD, et al: Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission. JAMA 288:189, 2002
    
64. Engelberg R, Carrell D, Krantz E, et al: Natural history of genital herpes simplex virus type 1 infection. Sex Transm Dis 30:174, 2003
    
65. Eskild A, Jeansson S, Stray-Pedersen B, et al: Herpes simplex virus type-2 infection in pregnancy. No risk of fetal death: Results from a nested case-control study within 35,940 women. Br J Obstet Gynaecol 109:1030, 2002
    
66. European Mode of Delivery Collaboration: Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: A randomized clinical trial. Lancet 353:1035, 1999
    
67. Fagnant RJ, Monif GRG: How rare is congenital herpes simplex? A literature review. J Reprod Med 34:417, 1989
    
68. Fauci AS: HIV and AIDS: 20 years of science. Nat Med 9:839, 2003
    
69. Fife KH, Katz BP, Brizendine EJ, et al: Cervical human papillomavirus deoxyribonucleic acid persists throughout pregnancy and decreases in the postpartum period. Am J Obstet Gynecol 180:1110, 1999
    
70. Fisman DN, Lipsitch M, Hook EW III, et al: Projection of the future dimensions and costs of the genital herpes simplex type 2 epidemic in the United States. Sex Transm Dis 29:608, 2002
    
71. Fiumara NJ, Fleming WL, Downing JG, et al: The incidence of prenatal syphilis at the Boston City Hospital. N Engl J Med 247:48, 1952
    
72. Gallo RC, Montagnier L: The discovery of HIV as the cause of AIDS. N Engl J Med 349:2283, 2003
    
73. Gayle HD: Curbing the global AIDS epidemic. N Engl J Med 348:1802, 2003
    
74. Genc M, Ledger WJ: Syphilis in pregnancy. Sex Transm Infect 76:73, 2000
    
75. Gerberding JL: Occupational exposure to HIV in health care settings. N Engl J Med 348:826, 2003
    
76. Gibbs RS, Schachter J: Chlamydial serology in patients with intra-amniotic infection and controls. Sex Transm Dis 14:213, 1987
    
77. Goldaber KG, Wendel PJ, McIntire DD, et al: Postpartum perineal morbidity after fourth degree perineal repair. Am J Obstet Gynecol 168:489, 1993
    
78. Golden MR, Marra CM, Holmes KK: Update on syphilis: Resurgence of an old problem. JAMA 290:1510, 2003
    
79. Goldenberg RL, Andrews WW, Yuan AC, et al: Sexually transmitted disease and adverse outcomes of pregnancy. Clin Perinatol 24:23, 1997
    
80. Goldenberg RL, Thompson C: The infectious origins of stillbirth. Am J Obstet Gynecol 189:861, 2003
    
81. Gray RH, Wabwire-Mangen F, Kigozi G, et al: Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda. Am J Obstet Gynecol 185:1209, 2001
    
82. Gust DA, Levine WC, St. Louis ME, et al: Mortality associated with congenital syphilis in the United States, 1992-1998. Pediatrics 109:E79, 2002
    
83. Hagensee ME, Slavinsky J 3rd, Gaffga CM, et al: Seroprevalence of human papillomavirus type 16 in pregnant women. Obstet Gynecol 94:653, 1999
    
84. Harger JH, Amortegui AJ, Meyer MP, et al: Characteristics of recurrent genital herpes simplex infections in pregnant women. Obstet Gynecol 73:367, 1989
    
85. Hensleigh PA, Andrews WW, Brown Z, et al: Genital herpes during pregnancy: Inability to distinguish primary and recurrent infections clinically. Obstet Gynecol 89:891, 1997
    
86. Hitti J, Watts DH, Burchett SK, et al: Herpes simplex virus seropositivity and reactivation at delivery among pregnant women infected with human immunodeficiency virus-1. Am J Obstet Gynecol 177:450, 1997
    
87. Hollier LM, Harstat TW, Sanchez PJ, et al: Fetal syphilis: Clinical and laboratory characteristics. Obstet Gynecol 97:947, 2001
    
88. Hollier LM, Hill J, Sheffield JS, et al: State laws regarding prenatal syphilis screening in the United States. Am J Obstet Gynecol 189:1178, 2003
    
89. Hoyme UB, Kiviat N, Eschenbach DA: The microbiology and treatment of late postpartum endometritis. Obstet Gynecol 68:226, 1986
    
90. Ickovics JR, Niccolai LM, Lewis JB, et al: High postpartum rates of sexually transmitted infections among teens: Pregnancy as a window of opportunity for prevention. Sex Transm Infect 79:469, 2003
    
91. Institute of Medicine, Committee on Prenatal and Newborn Screening for HIV Infection: HIV Screening of Pregnant Women and Newborns. Washington, DC, National Academy Press, 1991
    
92. International Perinatal HIV Group: The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1: A meta-analysis of 15 prospective cohort studies. N Engl J Med 340:977, 1999
    
93. Jacobson GF, Autry AM, Kirby RS, et al: A randomized controlled trial comparing amoxicillin and azithromycin for the treatment of Chlamydia trachomatis in pregnancy. Am J Obstet Gynecol 184:1352, 2001
    
94. John-Stewart G, Mbori-Ngacha D, Ekpini R, et al: Breastfeeding and transmission of HIV-1. J Acquir Immune Defic Syndr 35:196, 2004
    
95. Kacmar J, Cheh E, Montagno A, et al: A randomized trial of azithromycin versus amoxicillin for the treatment of Chlamydia trachomatis in pregnancy. Infect Dis Obstet Gynecol 9:197, 2001
    
96. Kahn JO, Walker BD: Acute human immunodeficiency virus type 1 infection. N Engl J Med 339:33, 1998
    
97. Kigozi GG, Brahmbhatt H, Wabwire-Mangen F, et al: Treatment of trichomonas in pregnancy and adverse outcomes of pregnancy: A subanalysis of a randomized trial in Rakai, Uganda. Am J Obstet Gynecol 189:1398, 2003
    
98. Kilby JM, Eron JJ: Novel therapies based on mechanisms of HIV-1 cell entry. N Engl J Med 348:2228, 2003
    
99. Kimberlin DW: Neonatal herpes simplex infection. Clin Microbiol Rev 17:1, 2004
    
100. Kimberlin DW, Rouse DJ: Genital herpes. N Engl J Med 350:1970, 2004
     
101. Kimberlin DW, Lin CY, Jacobs RF, et al: Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 108:223, 2001a
     
102. Kimberlin DW, Lin CY, Jacobs RF, et al: Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 108:230, 2001b
     
103. Kimberlin DF, Weller S, Whitley RJ, et al: Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy. Am J Obstet Gynecol 179:846, 1998
     
104. Klass PE, Brown ER, Pelton SI: The incidence of prenatal syphilis at the Boston City Hospital: A comparison across four decades. Pediatrics 94:24, 1994
     
105. Klebanoff MA, Carey JC, Hauth JC, et al: Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 345:487, 2001
     
106. Klein VR, Cox SM, Mitchell MD, et al: The Jarisch-Herxheimer reaction complicating syphilotherapy in pregnancy. Obstet Gynecol 75:375, 1990
     
107. Kochanek KD, Smith BL: Deaths: Preliminary data for 2002. National Vital Statistics Reports,Vol 52, No. 27. Hyattsville, MD, National Center for Health Statistics, 2004
     
108. Kohl KS, Markowitz LE, Koumans EH: Developments in the screening for Chlamydia trachomatis: A review. Obstet Gynecol Clin North Am 30:637, 2003
     
109. Koumans EH, Markowitz LE, Hogan V: Indications for therapy and treatment recommendations for bacterial vaginosis in nonpregnant and pregnant women: A synthesis of data. Clin Infect Dis 35:S152, 2002
     
110. Koumans EH, Sternberg M, Gwinn M, et al: Geographic variation of HIV infection in childbearing women with syphilis in the United States. AIDS 14:279, 2000
     
111. Kourtis AP, Bulterys M, Nesheim SR: Understanding the timing of HIV transmission from mother to infant. JAMA 285:709, 2001
     
112. Kuhn L, Steketee RW, Weedon J, et al: Distinct risk factors for intrauterine and intrapartum human immunodeficiency virus transmission and consequences for disease progression in infected children. Perinatal AIDS Collaborative Transmission Study. J Infect Dis 179:52, 1999
     
113. Lago EG, Rodrigues LC, Fiori RM, et al: Identification of two distinct profiles of maternal characteristics associated with risk. Sex Transm Dis 31:33, 2004
     
114. Laine C, Newschaffer CJ, Zhang D, et al: Adherence to antiretroviral therapy by pregnant women infected with human immunodeficiency virus: A pharmacy claims-based analysis. Obstet Gynecol 95:167, 2000
     
115. Landesman SH, Kalish LA, Burns DN, et al: Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. N Engl J Med 334:1617, 1996
     
116. Langenberg AGM, Corey L, Ashley RL, et al: A prospective study of new infections with herpes simplex virus type 1 and type 2. N Engl J Med 341:1432, 1999
     
117. Lewis SH, Reynolds-Kohler C, Fox HE, et al: HIV-1 in trophoblastic and villous Hofbauer cells, and haematological precursors in eight-week fetuses. Lancet 335:565, 1990
     
118. Lorenzi P, Spicher VM, Laubereau B, et al: Antiretroviral therapies in pregnancy: Maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study. AIDS 12:F241, 1998
     
119. Lossick JG: Treatment of sexually transmitted vaginosis/vaginitis. Rev Infect Dis 12:S665, 1990
     
120. Lucas MJ, Theriot SK, Wendel GD: Doppler systolic-diastolic ratios in pregnancies complicated by syphilis. Obstet Gynecol 77:217, 1991
     
121. Lukehart SA, Godornes C, Molini BJ, et al: Macrolide resistance in Treponema pallidum in the United States and Ireland. N Engl J Med 351:154, 2004
     
122. Lumbiganon P, Piaggio G, Villar J, et al: The epidemiology of syphilis in pregnancy. Int J STD AIDS 13:486, 2002
     
123. Mahon BE, Rosenman MB, Graham MF, et al: Postpartum Chlamydia trachomatis and Neisseria gonorrhoeae infections. Am J Obstet Gynecol 186:1320, 2002
     
124. Major CA, Towers CV, Lewis DF, et al: Expectant management of preterm rupture of membranes complicated by active recurrent genital herpes. Am J Obstet Gynecol 188:1551, 2003
     
125. Mandelbrot L, Landreau-Mascaro A, Rekacewicz C, et al: Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1. JAMA 285:2083, 2001
     
126. Manns A, Strickler HD, Wiktor SZ, et al: Low incidence of human papillomavirus type 16 antibody seroconversion in young children. Pediatr Infect Dis J 18:833, 1999
     
127. Maxwell GL, Watson WJ: Preterm premature rupture of membranes: Results of expectant management in patients with cervical cultures positive for group B streptococcus or Neisseria gonorrhoeae. Am J Obstet Gynecol 166:945, 1992
     
128. McFarlin BL, Bottoms SF, Dock BS, et al: Epidemic syphilis: Maternal factors associated with congenital infection. Am J Obstet Gynecol 170:535, 1994
     
129. Mertz GJ, Rosenthal SL, Stanberry LR: Is herpes simplex virus type 1 (HSV-1) now more common than HSV-2 in first episodes of genital herpes? Sex Transm Dis 30:801, 2003
     
130. Miller JM Jr: Recurrent chlamydial colonization during pregnancy. Am J Perinatol 15:307, 1998
     
131. Miller WC, Ford CA, Morris M, et al: Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA 291:2229, 2004
     
132. Miller JM Jr, Maupin RT, Mestad RE, et al: Initial and repeated screening for gonorrhea during pregnancy. Sex Transm Dis 30:728, 2003
     
133. Mindel A, Taylor J, Tideman RL, et al: Neonatal herpes prevention: A minor public health problem in some communities. Sex Transm Infect 76:287, 2000
     
134. Minkoff HL: Human immunodeficiency virus infection in pregnancy. Obstet Gynecol 101:797, 2003
     
135. Minkoff HL, Hershow R, Watts H, et al: The relationship of pregnancy to human immunodeficiency virus disease progression. Am J Obstet Gynecol 189:552, 2003
     
136. Minkoff HL, McCalla S, Delke I, et al: The relationship of cocaine use to syphilis and human immunodeficiency virus infections among inner-city parturient women. Am J Obstet Gynecol 163:521, 1990
     
137. Mitka M: US effort to eliminate syphilis moving forward. JAMA 283:1555, 2000
     
138. Money DM: Antiviral and antiretroviral use in pregnancy. Obstet Gynecol Clin North Am 30:731, 2003
     
139. Moodley D, Moodley J, Coovadia H, et al: A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis 187:725, 2003
     
140. Mwanyumba F, Galillard P, Inion I, et al: Placental inflammation and perinatal transmission of HIV-1. J Acquir Immune Defic Syndr 29:262, 2002
     
141. Myles TD, Elam G, Park-Hwang E, et al: The Jarisch-Herxheimer reaction and fetal monitoring changes in pregnant women treated for syphilis. Obstet Gynecol 92:859, 1998
     
142. Nahmias AJ, Josey WE, Naib ZM, et al: Perinatal risk associated with maternal genital herpes simplex virus infection. Am J Obstet Gynecol 110:825, 1971
     
143. Nathan L, Bohman VR, Sanchez PJ, et al: In utero infection with Treponema pallidum in early pregnancy. Prenat Diagn 17:119, 1997
     
144. Nelson DB, Macones G: Bacterial vaginosis in pregnancy: Current findings and future directions. Epidemiol Rev 24:102, 2002
     
145. Nobbenhuis MAE, Helmerhorst TJM, van den Brule AJC, et al: High-risk human papillomavirus clearance in pregnant women: Trends for lower clearance during pregnancy with a catch-up postpartum. Br J Cancer 87:75, 2002
     
146. Peipert JF: Clinical practice: Genital chlamydial infections. N Engl J Med 18:349, 2003
     
147. Petra Study Team: Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa and Uganda (Petra study): A randomized, double-blind, placebo-controlled trial. Lancet 359:1178, 2002
     
148. Piper JM, Shain RN, Korte JE, et al: Behavioral interventions for prevention of sexually transmitted diseases in women: A physician's perspective. Obstet Gynecol Clin North Am 30:659, 2003
     
149. Piscitelli SC, Gallicano KD: Interactions among drugs for HIV and opportunistic infections. N Engl J Med 344:984, 2001
     
150. Pope V, Fears MB: Serodia Treponema pallidum passive particle agglutination (TP-PA) test. In Larsen SA, Pope V, Jonnson RE, et al (eds): Supplement to A Manual of Tests for Syphilis, 9th ed. Washington, DC, American Public Health Association, 2000, p 365
     
151. Prober CG, Hensleigh PA, Boucher FD, et al: Use of routine viral cultures at delivery to identify neonates exposed to herpes simplex virus. N Engl J Med 318:887, 1988
     
152. Prober CG, Sullender WM, Yasukawa LL, et al: Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections. N Engl J Med 316:240, 1987
     
153. Ramsey PS, Vaules MB, Vasdev GM, et al: Maternal and transplacental pharmacokinetics of azithromycin. Am J Obstet Gynecol 188:714, 2003
     
154. Ramus R, Sheffield JS, Mayfield JA, et al: A randomized trial that compared oral cefixime and intramuscular ceftriaxone for the treatment of gonorrhea in pregnancy. Am J Obstet Gynecol 185:629, 2001
     
155. Rando RF, Lindheim S, Hasty L, et al: Increased frequency of detection of human papillomavirus deoxyribonucleic acid in exfoliated cervical cells during pregnancy. Am J Obstet Gynecol 161:50, 1989
     
156. Ratanajamit C, Skriver MV, Jepsen P, et al: Adverse pregnancy outcome in women exposed to acyclovir during pregnancy: A population-based observational study. Scand J Infect Dis 35:255, 2003
     
157. Read JS and the Committee on Pediatric AIDS: Human milk, breastfeeding, and transmission of human immunodeficiency virus type 1 in the United States. Pediatrics 112:1196, 2003
     
158. Read JS, Tuomala R, Kpamegan E, et al: Mode of delivery and postpartum morbidity among HIV-infected women: The women and infants transmission study. J Acquir Immune Defic Syndr 26:236, 2001
     
159. Reiff-Eldridge R, Heffner CR, Ephross SA, et al: Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: A pharmaceutical company commitment. Am J Obstet Gynecol 182:159, 2000
     
160. Richardson BA, John-Stewart GC, Hughes JP, et al: Breast milk infectivity in human immunodeficiency virus type 1-infected mothers. J Infect Dis 187:736, 2003
     
161. Roberts SW, Cox SM, Dax J, et al: Genital herpes during pregnancy: No lesions, no cesarean. Obstet Gynecol 85:261, 1995
     
162. Rolfs RT: Treatment of syphilis in 1993. Clin Infect Dis 20:23, 1995
     
163. Ross JDC: Systemic gonococcal infection. Genitourin Med 72:404, 1996
     
164. Rouse DJ, Stringer JS: An appraisal of screening for maternal type-specific herpes simplex virus antibodies to prevent neonatal herpes. Am J Obstet Gynecol 183:400, 2000
     
165. Sansom SL, Jamieson DJ, Farnham PG: Human immunodeficiency virus retesting during pregnancy: Costs and effectiveness in preventing perinatal transmission. Obstet Gynecol 102:782, 2003
     
166. Schmid GP, Sanders LL, Blount JH, et al: Chancroid in the United States: Reestablishment of an old disease. JAMA 258:3265, 1987
     
167. Schrag SJ, Arnold KE, Mohle-Boetani JC, et al: Prenatal screening for infectious diseases and opportunities for prevention. Obstet Gynecol 102:753, 2003
     
168. Schulte JM, Burkham S, Hamaker D, et al: Syphilis among HIV-infected mothers and their infants in Texas from 1988 to 1994. Sex Transm Dis 28:316, 2001
     
169. Schwartz DA, Larsen SA, Beck-Sague C, et al: Pathology of the umbilical cord in congenital syphilis: Analysis of 25 specimens using histochemistry and immunofluorescent antibody to Treponema pallidum. Hum Pathol 26:784, 1995
     
170. Schwartz DB, Greenberg MD, Daoud Y, et al: Genital condylomas in pregnancy: Use of trichloroacetic acid and laser therapy. Am J Obstet Gynecol 158:1407, 1988
     
171. Schwebke JR: Update of trichomoniasis. Sex Transm Infect 78:378, 2002
     
172. Scott LL: Prevention of perinatal herpes: Prophylactic antiviral therapy? Clin Obstet Gynecol 42:134, 1999
     
173. Scott LL, Alexander J: Cost-effectiveness of acyclovir suppression to prevent recurrent genital herpes in term pregnancy. Am J Perinatol 15:57, 1998
     
174. Scott LL, Hollier LM, McIntire D, et al: Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: An open-label trial. Infect Dis Obstet Gynecol 9:75, 2001
     
175. Scott LL, Hollier LM, McIntire D, et al: Acyclovir suppression to prevent recurrent genital herpes at delivery. Infect Dis Obstet Gynecol 10:71, 2002
     
176. Scott LL, Sanchez PJ, Jackson GL, et al: Acyclovir suppression to prevent cesarean section after first episode genital herpes in pregnancy. Obstet Gynecol 87:69, 1996
     
177. Scoular A: Using the evidence base on genital herpes: Optimizing the use of diagnostic tests and information provision. Sex Transm Infect 78:160, 2002
     
178. Sheffield J, Pybus C, Wendel G, et al: The effect of progesterone and pregnancy on HIV-1 co-receptor expression. Presented at the 25th Annual Meeting of the Society for Maternal-Fetal Medicine, Reno, Nevada, 7-12 February 2005
     
179. Sheffield JS, Fish DN, Hollier LM, et al: Acyclovir concentrations in human breast milk after valacyclovir administration. Am J Obstet Gynecol 186:100, 2002a
     
180. Sheffield JS, Hollier LM, Hill JB, et al: Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: A systematic review. Obstet Gynecol 102:1396, 2003
     
181. Sheffield JS, Sanchez PJ, Morris G, et al: Congenital syphilis after maternal treatment for syphilis during pregnancy. Am J Obstet Gynecol 186:569, 2002b
     
182. Sheffield JS, Sanchez PJ, Wendel GD Jr, et al: Placental histopathology of congenital syphilis. Obstet Gynecol 100:126, 2002c
     
183. Sheffield JS, Sigman A, McIntire D, et al: Disseminated gonococcal infection in women: A 24-year experience (Abstract No. 522). Presented at the Thirteenth Annual Meeting of the International Society for Sexually Transmitted Diseases Research, Denver, July 11-14, 1999
     
184. Silverberg MJ, Thorsen P, Lindeberg H, et al: Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis. Obstet Gynecol 101:645, 2003
     
185. Silverman NS, Sullivan M, Hochman M, et al: A randomized, prospective trial comparing amoxicillin and erythromycin for the treatment of Chlamydia trachomatis in pregnancy. Am J Obstet Gynecol 170:829, 1994
     
186. Silverstein AM: Congenital syphilis and the timing of immunogenesis in the human fetus. Nature 194:196, 1962
     
187. Smith EM, Ritchie JM, Yankowitz J, et al: Human papillomavirus prevalence and types in newborns and parents. Sex Transm Dis 31:1:57, 2004
     
188. Snyder RR, Hammond TL, Hankins GDV: Human papillomavirus associated with poor healing of episiotomy repairs. Obstet Gynecol 76:664, 1990
     
189. Soper D: Trichomoniasis: Under control or undercontrolled? Am J Obstet Gynecol 190:281, 2004
     
190. Sozio J, Ness RB: Chlamydial lower genital tract infection and spontaneous abortion. Infect Dis Obstet Gynecol 6:8, 1998
     
191. Sperling RS, Shapiro DE, McSherry GD, et al: Safety of the maternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 Study. AIDS 12:1805, 1998
     
192. Spitzer M, Krumholz BA, Seltzer VL: The multicentric nature of disease related to human papillomavirus infection of the female lower genital tract. Obstet Gynecol 73:303, 1989
     
193. Star J, Powrie R, Cu-Uvin S, et al: Should women with human immunodeficiency virus be delivered by cesarean? Obstet Gynecol 94:799, 1999
     
194. Steinbrook R: The AIDS epidemic in 2004. N Engl J Med. 351:115, 2004
     
195. Stratton P, Tuomala RE, Abboud R, et al: Obstetric and newborn outcomes in a cohort of HIV-infected pregnant women: A report of the women and infants transmission study. J Acquir Immune Defic Syndr Hum Retrovirol 20:179, 1999
     
196. Stringer EM, Stringer JS, Cliver SP, et al: Evaluation of a new testing policy for human immunodeficiency virus to improve screening rates. Obstet Gynecol 96:1004, 2001
     
197. Stringer JSA, Rouse DJ, Goldenberg RL: Prophylactic cesarean delivery for the prevention of perinatal human immunodeficiency virus transmission. JAMA 281:1946, 1999
     
198. Stuart GS, Castano PM: Sexually transmitted infections and contraceptives: Selective issues. Obstet Gynecol Clin North Am 30:795, 2003
     
199. Tenti P, Zappatore R, Migliora P, et al: Perinatal transmission of human papillomavirus from gravidas with latent infections. Obstet Gynecol 93:475, 1999
     
200. Tseng CJ, Liang CC, Soong YK, et al: Perinatal transmission of human papillomavirus in infants: Relationship between infection rate and mode of delivery. Obstet Gynecol 91:92, 1998
     
201. Tuomala RE, Shapiro DE, Mofenson LM: Antiretroviral therapy during pregnancy and the risk of an adverse outcome. N Engl J Med 346:1863, 2002
     
202. U.S. Preventive Services Task Force: Screening for chlamydial infection: Recommendations and rationale. Am J Prev Med 20:90, 2001
     
203. U.S. Public Health Services Panel on Clinical Practices for Treatment of HIV Infection: Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. March 23, 2004. Available at: http://AIDSinfo.nih.gov. Accessed March 2004a
     
204. U.S. Public Health Services Panel on Clinical Practices for Treatment of HIV Infection: Considerations for antiretroviral therapy in women. Supplement to guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. March 23, 2004. Available at: http://AIDSinfo.nih.gov. Accessed March 2004b
     
205. U.S. Public Health Service Task Force Perinatal HIV Guidelines Working Group: Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. November 26, 2003. Available at: http://AIDSinfo.nih.gov. Accessed March 2004
     
206. Wald A, Ashley-Morrow R: Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection. Clin Infect Dis 35:S173, 2002
     
207. Wald A, Huang M-L, Carrell D, et al: Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: Comparison with HSV isolation in cell culture. J Infect Dis 188:1345, 2003
     
208. Wald A, Zeh J, Selke S, et al: Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 342:844, 2000
     
209. Wald A, Zeh J, Selke S, et al: Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 333:770, 1995
     
210. Walker GJ: Antibiotics for syphilis diagnosed during pregnancy. Cochrane Database Syst Rev 3:CD001143, 2001
     
211. Warner L, Rohcat RW, Fichtner RR, et al: Missed opportunities for congenital syphilis prevention in an urban southeastern hospital. Sex Transm Dis 28:92, 2001
     
212. Watson-Jones D, Changalucha J, Gumodoka B, et al: Syphilis in pregnancy in Tanzania. I. Impact of maternal syphilis on outcome of pregnancy. J Infect Dis 186:940, 2002a
     
213. Watts DH: Management of human immunodeficiency virus infection in pregnancy. N Engl J Med 346:1879, 2002
     
214. Watts DH, Balasubramanian R, Maupin RT Jr, et al: Maternal toxicity and pregnancy complications in human immunodeficiency virus-infected women receiving antiretroviral therapy: PACTG 316. Am J Obstet Gynecol 190:506, 2004
     
215. Watts DH, Koutsky LA, Holmes KK, et al: Low risk of perinatal transmission of human papillomavirus: Results from a prospective cohort study. Am J Obstet Gynecol 178:365, 1998
     
216. Wehbeh HA, Ruggeirio RM, Shahem SR, et al: Single-dose azithromycin for Chlamydia in pregnant women. J Reprod Med 43:509, 1998
     
217. Wendel GD: Gestational and congenital syphilis. Clin Perinatol 15:287, 1988
     
218. Wendel GD, Cunningham FG: Sexually transmitted diseases in pregnancy. In Williams Obstetrics, 18th ed. (Suppl 13). Norwalk, CT, Appleton & Lange, August/September 1991
     
219. Wendel GD Jr, Sanchez PJ, Peters MT, et al: Identification of Treponema pallidum in amniotic fluid and fetal blood from pregnancies complicated by congenital syphilis. Obstet Gynecol 78:890, 1991
     
220. Wendel GD Jr, Sheffield JS, Hollier LM, et al: Treatment of syphilis in pregnancy and prevention of congenital syphilis. Clin Infect Dis 35:S200, 2002
     
221. Wendel GD Jr, Stark BJ, Jamison RB, et al: Penicillin allergy and desensitization in serious infections during pregnancy. N Engl J Med 312:1229, 1985
     
222. Wiley DJ, Douglas J, Beutner K, et al: External genital warts: Diagnosis, treatment and prevention. Clin Infect Dis 35:S210, 2002
     
223. Wilkinson D, Barton S, Cowan F: HSV-2 specific serology should not be offered routinely to antenatal patients. Rev Med Virol 10:145, 2000
     
224. Winer RL, Koutsky LA: Delivering reassurance to parents: Perinatal human papillomavirus transmission is rare. Sex Transm Dis 31:63, 2004
     
225. Wittek AE, Yeager AS, Au DS, et al: Asymptomatic shedding of herpes simplex virus from the cervix and lesion site during pregnancy: Correlation of antepartum shedding with shedding at delivery. Am J Dis Child 138:439, 1984
     
226. World Health Organization: Effect of breastfeeding on mortality among HIV-infected women. WHO Statement, June 7, 2001. Available at: http://www.who.int/reproductive-health/rtis/MTCT/WHO_Statement_on_breast_feeding_June_2001.html. Accessed March, 2004
     
227. Wortley PM, Lindegren ML, Fleming PL: Successful implementation of perinatal HIV prevention guidelines. MMWR 50:17, 2001
     
228. Yip L, Sweeny PJ, Bock BF: Acute suppurative salpingitis with concomitant intrauterine pregnancy. Am J Emerg Med 11:476, 1993
     
229. Young H: Guidelines for serological testing for syphilis. Sex Transm Infect 75:403, 2000
     
230. Zenker PN, Rolfs RT: Treatment of syphilis, 1989. Rev Infect Dis 12:S590, 1990